Marc Hedrick, President & CEO of Plus Therapeutics, recently joined Karen Jagoda on the Empowered Patient Podcast for an in‑depth discussion on the company’s mission to advance care for patients with central nervous system (CNS) cancers.
During the interview, Dr. Hedrick provided a comprehensive overview of Plus Therapeutics’ work across diagnostics, targeted radiotherapy, and data‑driven clinical development, all aimed at improving outcomes for patients facing some of the most challenging cancers in neuro‑oncology.
Addressing Unmet Needs in Neuro‑Oncology
CNS cancers and metastatic disease affecting the brain and spinal cord remain areas of significant unmet medical need. In the conversation, Dr. Hedrick discussed how Plus Therapeutics is focused on developing innovative solutions that address the unique biological and clinical challenges of treating cancer within the central nervous system.
The discussion highlighted the importance of precision—both in diagnosis and therapy—to better inform treatment decisions and enable more effective, patient‑centered care.
Integrating Diagnostics, Therapeutics, and Data
A key theme of the podcast was the value of integrating advanced diagnostics with targeted radiotherapeutic approaches. Dr. Hedrick outlined how Plus Therapeutics and CNSide Diagnostics are working to generate high‑quality clinical data that can support more informed decision‑making for clinicians and ultimately improve patient outcomes.
By combining innovative diagnostic capabilities with targeted treatment strategies, the company aims to bring greater clarity to complex CNS disease states and support the development of more personalized therapeutic approaches.
A Patient‑Centered Vision for Progress
Throughout the interview, Dr. Hedrick emphasized the importance of keeping patients at the center of innovation—from clinical trial design to regulatory strategy and commercialization. The conversation reinforced Plus Therapeutics’ commitment to collaboration, scientific rigor, and long‑term impact in neuro‑oncology.
The Empowered Patient Podcast provides a valuable forum for sharing insights on how emerging technologies and thoughtful clinical development can help move the field forward.
Listen to the Full Interview
Listen to the full discussion with Marc Hedrick on the Empowered Patient Podcast:
https://lnkd.in/ggj2cc_p
Plus Therapeutics appreciates the opportunity to share its vision and progress with the patient and clinical community and looks forward to continuing the conversation as its CNS‑focused programs advance.
Recent Comments